| No.of Investor complaints pending at the beginning of the quarter | No.of Investor complaints received during the quarter | No.of Investor complaints disposed of during the quarter | No.of Investor complaints unresolved at the end of the quarter |
|---|
| 0 | 1 | | |
| |
| | Announcement under Regulation 30 (LODR)-Press Release / Media Release | 17/10/22 12:14 | Company Update |  |
| | Please find enclosed a Press Release on 'India's Best Managed Companies' awarded to Ajanta Pharma Ltd. by Deloitte. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 | 13/10/22 11:45 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 13, 2022 for Aayush Agrawal Trustee Aayush Agrawal Trust | |
| |
| | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 10/10/22 12:03 | Company Update | |
| | We are pleased to enclose herewith certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2022 received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company. | |
| |
| | Increase In Volume
| 04/10/22 10:54 | Company Update | |
| | In this regard we hereby clarify that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), we have timely disclosed to the Exchanges all the information/events that have a bearing on the operations/performance of the Company and no such material information /event have remained to be disclosed.
Since the shares of the Company are freely traded on the Stock Exchange, the Company .... | |
| |
| | Closure of Trading Window | 30/09/22 11:05 | Insider Trading / SAST | |
| | Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and 'Ajanta's Code of Conduct for Insiders', the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (as defined in the Code) from close of business hours of 30th September 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the second quarter and half year ended 30th September 2022. | |
| |
| | Closure of Trading Window | 30/09/22 11:00 | Insider Trading / SAST | |
| | Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and 'Ajanta's Code of Conduct for Insiders', the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (as defined in the Code) from close of business hours of 30th September 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the second quarter and half year ended 30th September 2022. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 19/09/22 17:05 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 19, 2022 for Aayush Agrawal, Trustee Aayush Agrawal Trust | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 14/09/22 15:32 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 14, 2022 for Ravi Agrawal, Trustee Ravi Agrawal Trust | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 12/09/22 10:54 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 08, 2022 for Ravi P Agrawal, trustee Ravi Agrawal Trust | |
| |
| | US FDA Inspection Of Our Dahej Facility | 12/09/22 10:43 | Company Update | |
| | This is to inform you that our formulation facility at Dahej was inspected by US FDA from 5th September 2022 to 9th September 2022.
At the end of the inspection, Form 483 was issued to us with 2 procedural observations. We are in the process of responding to the same within the stipulated time prescribed by US FDA. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 12/09/22 10:37 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 07, 2022 for Ravi Agrawal, Trustee Ravi Agrawal Trust | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 05/09/22 17:29 | Company Update | |
| | Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst/Institutional Investor Meeting with the Company. | |
| |
| | Business Responsibility and Sustainability Reporting (BRSR) | 01/09/22 12:34 | | |
| | Pursuant to your e-mail dated 1st September 2022, please find enclosed BRSR for the financial year 2021-22.
The same is being separately submitted as advised vide the above-referred communication.
This is for your information and records. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 06/08/22 12:09 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 05, 2022 for Aayush Agrawal, trustee Aayush Agrawal Trust | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 | 04/08/22 17:40 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 04, 2022 or Aayush Agrawal (Trustee Aayush Agrawal Trust) | |
| |
| | Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015) | 04/08/22 17:20 | AGM/EGM | |
| | Ajanta Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here | |
| |
| | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | 04/08/22 16:44 | AGM/EGM | |
| | Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the following:
a. Details of voting results through remote e-voting and at the AGM on each of the resolutions set out in the notice;
b. Consolidated Scrutinizer's Report dated 4th August 2022 on remote e-voting and at the AGM. | |
| |
| | Proceeding Of 43Rd Annual General Meeting | 04/08/22 16:42 | AGM/EGM | |
| | Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith summary of proceedings of 43rd Annual General Meeting of the Company held on 4th August 2022 through Video- conference/Other Audio-Visual Means. | |
| |
| | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | 03/08/22 18:35 | Company Update | |
| | Further to our communication dated 29th July 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed written transcript of the earnings call held on 28th July 2022 at 5.00 p.m.
Further, written transcript has been uploaded on the Company's website and can be accessed through the link:
http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ1(Apr-Jun)2022-23.pdf
This .... | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 03/08/22 13:44 | Company Update | |
| | Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst/Institutional Investor Meeting with the Company. | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 29/07/22 12:38 | Company Update | |
| | Pursuant to Regulation 47 of the Listing Regulations, please find enclosed copies of financial results of the Company for the quarter ended 30th June 2022 published in following newspapers on 29th July 2022:
1. Mumbai edition of Economic Times and
2. Mumbai edition of Maharashtra Times;
This is for your information and record. | |
| |
| | Audio Recording Of Earnings Call Conducted On 28Th July 2022 | 29/07/22 10:32 | Company Update | |
| | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 28th July 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link:
http://www.ajantapharma.com/AdminData/Results/EarningsCallAudioQ1(Apr-Jun)2022-23.mp3
Written transcript of the same will be submitted in due course.
This is for your information and records please. | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 21/07/22 09:53 | Company Update | |
| | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 28th July 2022, post Board meeting.
This is for your information and records please. | |
| |
| | Board Meeting Intimation for Considering And Approving Unaudited Consolidated And Standalone Financial Results | 20/07/22 19:20 | Board Meeting | |
| | AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2022 ,inter alia, to consider and approve Unaudited consolidated and standalone financial results of the Company for the first quarter ended 30th June 2022. | |
| |
| | Updates on Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 13/07/22 11:50 | Insider Trading / SAST | |
| | The Exchange has received Updates on Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 12, 2022 for Ravi P Agrawal, trustee Ravi Agrawal Trust | |
| |
| | Statement Of Investor Complaints For The Quarter Ended June 2022 | 13/07/22 11:20 | Company Update | |
| | | No.of Investor complaints pending at the beginning of the quarter | No.of Investor complaints received during the quarter | No.of Investor complaints disposed of during the quarter | No.of Investor complaints unresolved at the end of the quarter |
|---|
| 0 | 2 | | | | | | | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 13/07/22 11:17 | Company Update | | | | We are pleased to enclose herewith certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2022 received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company. | | | | | | Announcement under Regulation 30 (LODR)-Newspaper Publication | 07/07/22 14:07 | Company Update | | | | Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers regarding e-voting information for the 43rd Annual General Meeting of the Company in terms of Section 108 of the Companies Act, 2013 read with Rule 20 of Companies (Management and
Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in the following newspapers .... | | | | | | Announcement under Regulation 30 (LODR)-Newspaper Publication | 04/07/22 08:26 | Company Update | | | | Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers in terms of Circular No. 20/2020 dated 5th May 2020 issued by Ministry of Corporate Affairs, inter-alia, intimating that 43rd Annual General Meeting of the Company will be held on 4th August 2022 through Video Conferencing/Other Audio-Visual Means, in the following newspapers on 2nd July 2022:
1. Mumbai edition of Economic Times;
2. Mumbai .... | | | | | | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 01/07/22 16:21 | Insider Trading / SAST | | | | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 01, 2022 for Ravi P Agrawal, trustee Ravi Agrawal Trust | | | | | | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 28/06/22 11:18 | | | | | Information on loss of shares | | | | | | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 27/06/22 14:09 | Insider Trading / SAST | | | | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 27, 2022 for Aayush Agrawal, trustee Aayush Agrawal Trust | | | | | | Announcement under Regulation 30 (LODR)-Allotment | 24/06/22 18:35 | Company Update | | | | The Company has allotted 4,27,08,385 Bonus Equity Shares of Rs. 2/- each as fully-paid up Bonus Equity Shares, in the proportion of 1:2, to the eligible Members whose names appeared on the register of Members/list of beneficial owners as on 23rd June 2022, i.e. record date fixed for this purpose.
Consequently, the paid-up Equity Share Capital of the Company stands increased from Rs. 17,08,33,540 divided into 8,54,16,770 Equity Shares of Rs. 2/- .... | | | | | | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 | 24/06/22 09:24 | Insider Trading / SAST | | | | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 23, 2022 for Aayush Agrawal, trustee Aayush Agrawal Trust | | | | | | Intimation Of Annual General Meeting | 21/06/22 14:48 | AGM/EGM | | | | Forty-Third (43rd) Annual General Meeting ('AGM') of the Company will be held on Thursday, 4th August 2022 at 11.00 a.m. through Video-conference or Other Audio-Visual Means. | | | | | | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 03/06/22 12:49 | Insider Trading / SAST | | | | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 03, 2022 for Ravi Agrawal, Trustee Ravi Agrawal Trust | | | |
|
| |
Archives |
<< Previous | Next >>
|
|
<< Back To Announcements
|